A carregar...

Validation and clinical utility of prostate cancer biomarkers

To improve future drug development and patient management for patients with castration-resistant prostate cancer (CRPC), surrogate biomarkers that are linked to relevant outcomes are urgently needed. A biomarker must be measurable, reproducible, linked to relevant clinical outcomes, and demonstrate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Scher, Howard I., Morris, Michael J., Larson, Steven, Heller, Glenn
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3790270/
https://ncbi.nlm.nih.gov/pubmed/23459624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2013.30
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!